BIVDA Press Releases

25Oct

BIVDA Launches IVD Value Story

The British In Vitro Diagnostics Association (BIVDA) has today (25 October) launched its new report examining “The Value of IVDs”.

 

The eight page report examines how in vitro diagnostics (IVDs) are delivering value for patients, the NHS and the UK economy. The document is supported by a range of case studies focused around three key themes:

 

  • Improvement: Empowering patients for better outcomes, diagnosis and treatment
  • Impact: Increasing efficiencies and savings within the NHS
  • Investment: Contribution To The UK economy

 

Within these themes, the case studies cover a wide range of topics including antimicrobial resistance, screening, early diagnosis and wound care. The report also identifies five key recommendations for change to ensure the continuing success of the IVD industry in a post-Brexit landscape.

 

Commenting on the report, Doris-Ann Williams MBE, Chief Executive of BIVDA, said:

 

“The contribution of IVDs to the health and wealth of our nation should not be underestimated. Approximately 70% of clinical decisions are made using IVDs but despite the differences they can make to patient pathways, a glass ceiling remains when it comes to adoption and uptake across the NHS.

“Through this report, we hope to clearly demonstrate the tangible benefits that IVDs are already delivering for patients, the NHS and the UK economy. If IVDs were adopted more widely, we would be able to build on this progress and provide better outcomes for all”.

The Value of IVDs is available to download from the BIVDA website.- The Value of IVDs, The Value Story Case Studies

Related

BIVDA, ABPI and CRUK release briefing on new arrangements for commissioning and funding of six molecular diagnostic tests for cancer

BIVDA, ABPI and CRUK have released a stakeholder briefing to clarify the new arrangements for commis...

Read More >

BIVDA Response to Cancer Research UK Report on Pathology Services

Cancer Research UK have today (23 November 2016) published a report which finds that UK pathology se...

Read More >

UK continues to lag behind the European market for in-vitro diagnostic expenditure

IVD Market Statistics Report 2017 highlights differences in total healthcare expenditure and wide va...

Read More >

BIVDA statement on the publication of the NHS Long Term Plan

Doris-Ann Williams, Chief Executive of BIVDA, comments on the publication of the NHS Long Term Plan ...

Read More >

Press Statement - Government Meets 100,000k testing target

Please see below a short statement from BIVDA Chief Executive Doris-Ann Williams regarding the Gover...

Read More >

Member Press Release - Stream Bio collaborates with MIP Diagnostics Ltd. on a rapid diagnostic and mass screening test for COVID-19

PRESS RELEASE22nd April 2020Stream Bio, a company that develops and manufactures a range of transfor...

Read More >